##Aharoni-Simon, M., Hann-Obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011). Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice. Laboratory Investigation, 91(7), 1018-1028. ##Akimoto, T., Sorg, B. S., & Yan, Z. (2004). Real-time imaging of peroxisome proliferator-activated receptor-γ coactivator-1α promoter activity in skeletal muscles of living mice. American Journal of Physiology-Cell Physiology, 287(3), C790-C796. ##Annie, L., Gurusubramanian, G., & Roy, V. K. (2019). Dexamethasone mediated downregulation of PGC-1α and visfatin regulates testosterone synthesis and antioxidant system in mouse testis. Acta Histochemica, 121(2), 182-188. ##Bagherniya, M., Nobili, V., Blesso, C. N., & Sahebkar, A. (2018). Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Pharmacological Research, 130, 213-240. ## Besse-Patin, A., Léveillé, M., Oropeza, D., Nguyen, B. N., Prat, A., & Estall, J. L. (2017). Estrogen signals through peroxisome proliferator-activated Receptor− γ coactivator 1α to reduce oxidative damage associated with diet-induced fatty liver disease. Gastroenterology, 152(1), 243-256. ## Cao, W., Collins, Q. F., Becker, T. C., Robidoux, J., Lupo, E. G., Xiong, Y., Daniel, K. W., Floering, L., & Collins, S. (2005). p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. Journal of Biological Chemistry, 280(52), 42731-42737. ##Cao, W., Daniel, K. W., Robidoux, J., Puigserver, P., Medvedev, A. V., Bai, X., Floering, L. M., Spiegelman, B. M., & Collins, S. (2004). p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Molecular and cellular biology, 24(7), 3057-3067. ## Chavanelle, V., Boisseau, N., Otero, Y. F., Combaret, L., Dardevet, D., Montaurier, C., Delcros, G., Peltier, S. L., & Sirvent, P. (2017). Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice. Scientific reports, 7(1), 204. ##Christ-Crain, M., Kola, B., Lolli, F., Fekete, C., Seboek, D., Wittman, G., & Ajodha, S. (2008). Harvey-White j, Kunos G, Müller B. Pralong F, Aubert G, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M, 1672-1683. ##Cole, T., Wilcox, H., & Heimberg, M. (1982). Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism. Journal of lipid research, 23(1), 81-91. ##Croce, M. A., Eagon, J. C., LaRiviere, L. L., Korenblat, K. M., Klein, S., & Finck, B. N. (2007). Hepatic lipin 1β expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes, 56(9), 2395-2399. ##Cui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., & Shen, L. (2019). Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. The Journal of clinical investigation, 129(6), 2266-2278. ##Czock, D., Keller, F., Rasche, F. M., & Häussler, U. (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical pharmacokinetics, 44, 61-98. ## Dolatabadi, A. A., & Mahboubi, M. (2015). A study of the influence of dexamethasone on lipid profile and enzyme lactate dehydrogenase. Journal of medicine and life, 8(Spec Iss 3), 72. ##Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019). Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European journal of sport science, 19(7), 994-1003. ##Fernandez-Marcos, P. J., & Auwerx, J. (2011). Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. The American journal of clinical nutrition, 93(4), 884S-890S. ##Finck, B. N., & Kelly, D. P. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. The Journal of clinical investigation, 116(3), 615-622. ##Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefebvre, P., Taskinen, M.-R., Van Hul, W., & Mertens, I. (2015). PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. Journal of hepatology, 63(1), 164-173. ##Gibala, M. J., McGee, S. L., Garnham, A. P., Howlett, K. F., Snow, R. J., & Hargreaves, M. (2009). Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1α in human skeletal muscle. Journal of applied physiology, 106(3), 929-934. ##Goto, M., Terada, S., Kato, M., Katoh, M., Yokozeki, T., Tabata, I., & Shimokawa, T. (2000). cDNA cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochemical and biophysical research communications, 274(2), 350-354. ## Gounarides, J. S., Korach-André, M., Killary, K., Argentieri, G., Turner, O., & Laurent, D. (2008). Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology, 149(2), 758-766. ##Gupta, A. P., Singh, P., Garg, R., Valicherla, G. R., Riyazuddin, M., Syed, A. A., Hossain, Z., & Gayen, J. R. (2019). Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice. Biomedicine & Pharmacotherapy, 116, 108959. ## Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., & Puigserver, P. (2001). CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature, 413(6852), 179-183. ##Hoene, M., Franken, H., Fritsche, L., Lehmann, R., Pohl, A., Häring, H., Zell, A., Schleicher, E., & Weigert, C. (2010). Activation of the mitogen-activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise. Diabetologia, 53, 1131-1141. ##Holloszy, J. (2008). Regulation by exercise of skeletal muscle content of mitochondria and GLUT4. J Physiol Pharmacol, 59(Suppl 7), 5-18. ##Høydal, M. A., Wisløff, U., Kemi, O. J., & Ellingsen, Ø. (2007). Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. European Journal of Preventive Cardiology, 14(6), 753-760. ##Huang, Y., Chen, K., Ren, Q., Yi, L., Zhu, J., Zhang, Q., & Mi, M. (2018). Dihydromyricetin attenuates dexamethasone-induced muscle atrophy by improving mitochondrial function via the PGC-1α pathway. Cellular physiology and biochemistry, 49(2), 758-779. ##Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020). Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma. International journal of molecular sciences, 21(4), 1525. ##Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., Baker, M. K., Chuter, V. H., Caterson, I. D., & George, J. (2015). Effect of aerobic exercise training dose on liver fat and visceral adiposity. Journal of hepatology, 63(1), 174-182. ##Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., & Knoefel, W. T. (2015). Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell metabolism, 21(5), 739-746. ##Kumar, V. H., Im, N. N., Huilgol, S. V., Yendigeri, S. M., Narendar, K., & Rajasekhar, C. (2015). Dose dependent hepatic and endothelial changes in rats treated with dexamethasone. Journal of clinical and diagnostic research: JCDR, 9(5), FF08. ##Lavoie, J.-M., & Gauthier, M.-S. (2006). Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cellular and Molecular Life Sciences CMLS, 63, 1393-1409. ##Laye, M. J., Rector, R. S., Borengasser, S. J., Naples, S. P., Uptergrove, G. M., Ibdah, J. A., Booth, F. W., & Thyfault, J. P. (2009). Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue. Journal of applied physiology, 106(1), 161-168. ##Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., & Wahli, W. (1994). Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. Journal of Biological Chemistry, 269(40), 24527-24530. ##Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., & Bernal-Mizrachi, C. (2005). PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS biology, 3(4), e101. ##Lin, J., Handschin, C., & Spiegelman, B. M. (2005). Metabolic control through the PGC-1 family of transcription coactivators. Cell metabolism, 1(6), 361-370.Liu, Z. L., Xie, L. Z., Zhu, J., Li, G. Q., Grant, S. J., & Liu, J. P. (2013). Herbal medicines for fatty liver diseases. Cochrane Database of Systematic Reviews(8). ##Luan, G., Li, G., Ma, X., Jin, Y., Hu, N., Li, J., Wang, Z., & Wang, H. (2019). Dexamethasone-induced mitochondrial dysfunction and insulin resistance-study in 3T3-L1 adipocytes and mitochondria isolated from mouse liver. Molecules, 24(10), 1982. ##LUCIC VRDOLJAK, A., Bradamante, V., RADIC, B., Peraica, M., Fuchs, R., & Reiner, Z. (2005). Butyrylcholinesterase activity and plasma lipids in dexamethasone treated rats. Acta pharmaceutica, 55(2), 177-185. ##Mahendran, P., & Devi, C. S. (2001). Effect of Garcinia cambogia extract on lipids and lipoprotein composition in dexamethasone administered rats. Indian journal of physiology and pharmacology, 45(3), 345-350. ##Manco, M. (2017). Insulin resistance and NAFLD: A dangerous liaison beyond the genetics. Children, 4(8), 74. ##Mani, V., Lee, S.-K., Yeo, Y., & Hahn, B.-S. (2020). A metabolic perspective and opportunities in pharmacologically important safflower. Metabolites, 10(6), 253. ##Matiello, R., Fukui, R. T., Silva, M. E., Rocha, D. M., Wajchenberg, B. L., Azhar, S., & Santos, R. F. (2010). Differential regulation of PGC-1α expression in rat liver and skeletal muscle in response to voluntary running. Nutrition & metabolism, 7(1), 1-8. ##Morris, E. M., Meers, G. M., Booth, F. W., Fritsche, K. L., Hardin, C. D., Thyfault, J. P., & Ibdah, J. A. (2012). PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion. American Journal of Physiology-Gastrointestinal and Liver Physiology, 303(8), G979-G992. ##Nader, N., Ng, S. S. M., Lambrou, G. I., Pervanidou, P., Wang, Y., Chrousos, G. P., & Kino, T. (2010). AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Molecular endocrinology, 24(9), 1748-1764. ##Nikroo, H., Hosseini, S. R. A., Fathi, M., Sardar, M. A., & Khazaei, M. (2020). The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats. Physiology & Behavior, 227, 113149. ##Nimrouzi, M., Ruyvaran, M., Zamani, A., Nasiri, K., & Akbari, A. (2020). Oil and extract of safflower seed improve fructose induced metabolic syndrome through modulating the homeostasis of trace elements, TNF-α and fatty acids metabolism. Journal of ethnopharmacology, 254, 112721. ##Oh, S., So, R., Shida, T., Matsuo, T., Kim, B., Akiyama, K., Isobe, T., Okamoto, Y., Tanaka, K., & Shoda, J. (2017). High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease. Scientific reports, 7(1), 43029. ##Ok, D.-P., Ko, K., & Bae, J. Y. (2018). Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits. Lipids in health and disease, 17, 1-7. ##Oliveira, C. P., de Lima Sanches, P., de Abreu-Silva, E. O., & Marcadenti, A. (2016). Nutrition and physical activity in nonalcoholic fatty liver disease. Journal of diabetes research, 2016. ##Peeters, A., & Baes, M. (2010). Role of PPARα in hepatic carbohydrate metabolism. PPAR research, 2010. ##Piccinin, E., Villani, G., & Moschetta, A. (2019). Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nature reviews Gastroenterology & hepatology, 16(3), 160-174. ##Pilegaard, H., Saltin, B., & Neufer, P. D. (2003). Exercise induces transient transcriptional activation of the PGC‐1α gene in human skeletal muscle. In: Wiley Online Library. ##Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92(6), 829-839. ##Rahnert, J. A., Zheng, B., Hudson, M. B., Woodworth-Hobbs, M. E., & Price, S. R. (2016). Glucocorticoids alter CRTC-CREB signaling in muscle cells: impact on PGC-1α expression and atrophy markers. PLoS One, 11(7), e0159181. ##Rasmussen, M. K., Thøgersen, R., Lindholm, P. H., Bertram, H. C., & Pilegaard, H. (2023). Hepatic PGC-1α has minor regulatory effect on the liver transcriptome and metabolome during high fat high fructose diet and exercise training. Gene, 851, 147039. ##Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020). PGC-1α, inflammation, and oxidative stress: an integrative view in metabolism. Oxidative medicine and cellular longevity, 2020. ##Russell, A. P., Feilchenfeldt, J., Schreiber, S., Praz, M., Crettenand, A., Gobelet, C., Meier, C. A., Bell, D. R., Kralli, A., & Giacobino, J.-P. (2003). Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes, 52(12), 2874-2881. ##Severino, C., Brizzi, P., Solinas, A., Secchi, G., Maioli, M., & Tonolo, G. (2002). Low-dose dexamethasone in the rat: a model to study insulin resistance. American Journal of Physiology-Endocrinology and Metabolism, 283(2), E367-E373. ##Shalam, M., Harish, M., & Farhana, S. (2006). Prevention of dexamethasone-and fructose-induced insulin resistance in rats by SH-01D, a herbal preparation. Indian Journal of Pharmacology, 38(6), 419. ##Sharabi, K., Tavares, C. D., Rines, A. K., & Puigserver, P. (2015). Molecular pathophysiology of hepatic glucose production. Molecular aspects of medicine, 46, 21-33. ##Terada, S., Goto, M., Kato, M., Kawanaka, K., Shimokawa, T., & Tabata, I. (2002). Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochemical and biophysical research communications, 296(2), 350-354. ##Van der Windt, D. J., Sud, V., Zhang, H., Tsung, A., & Huang, H. (2018). The effects of physical exercise on fatty liver disease. Gene Expression The Journal of Liver Research, 18(2), 89-101. ##Viana, A. Y., Sakoda, H., Anai, M., Fujishiro, M., Ono, H., Kushiyama, A., Fukushima, Y., Sato, Y., Oshida, Y., & Uchijima, Y. (2006). Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression. Diabetes research and clinical practice, 73(2), 135-142. ##Wan, X., Zhu, X., Wang, H., Feng, Y., Zhou, W., Liu, P., Shen, W., Zhang, L., Liu, L., & Li, T. (2020). PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response. The FASEB Journal, 34(8), 10751-10761. ##Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N. (2020). PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. International journal of molecular sciences, 21(6), 2061. ##Weickert, M., & Pfeiffer, A. (2006). Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia, 49, 1732-1741. ##Westerbacka, J., Kolak, M., Kiviluoto, T., Arkkila, P., Sirén, J., Hamsten, A., Fisher, R. M., & Yki-Järvinen, H. (2007). Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes, 56(11), 2759-2765. ##Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferré, P., Foufelle, F., & Carling, D. (2000). Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Molecular and cellular biology, 20(18), 6704-6711. ##Xu, L., Xia, H., Ni, D., Hu, Y., Liu, J., Qin, Y., Zhou, Q., Yi, Q., & Xie, Y. (2020). High-dose dexamethasone manipulates the tumor microenvironment and internal metabolic pathways in anti-tumor progression. International journal of molecular sciences, 21(5), 1846. ##Yoon, M. (2009). The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions. Pharmacological Research, 60(3), 151-159. ##Zakrzewska, K. E., Cusin, I., Stricker-Krongrad, A., Boss, O., Ricquier, D., Jeanrenaud, B., & Rohner-Jeanrenaud, F. (1999). Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes, 48(2), 365-370. ##
)